The University of North Carolina at Chapel Hill (UNC-CH) received a $324,440 Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837). The funding will support a study to assess the contribution of epigenetics to cardiovascular disease risk in African American women. The project aims to identify epigenetic biomarkers of cardiovascular disease and its environmental determinants, and evaluate if these biomarkers can improve risk prediction assessments. This aligns with NHLBI's mission to reduce cardiovascular disease burden in populations with disparities in disease risk. The project period runs from September 2024 through June 2028.
Generated 3/4/25, 4:38 AM